COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 16:00, il y a 2 années 6 mois Cantabio Pharmaceuticals Awarded Major Grant from The Michael J. Fox Foundation for the Development of a novel DJ-1 Protein Replacement Therapy for the Treatment of Parkinson’s Disease Cantabio Pharmaceuticals, Inc. receives major grant from MJFF for the development of DJ-1 replacement therapy aimed at treating Parkinson's disease by increasing DJ-1 levels in patients and preventing disease progression Precision Medicine Cantabio Pharmaceuticals MJFF Grant DJ-1 Replacement Therapy Parkinson's Disease
Publié le 02/09/2026 à 18:00, il y a 43 minutes Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 août 2026
Publié le 02/09/2026 à 18:00, il y a 43 minutes Outstanding shares and voting rights statement at 31 August 2026
Publié le 02/09/2026 à 17:45, il y a 58 minutes Disclosure of shares outstanding and voting rights - 02.09.2026
Publié le 02/09/2026 à 15:00, il y a 3 heures 43 minutes Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Publié le 02/09/2026 à 14:30, il y a 4 heures 13 minutes Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Publié le 02/09/2026 à 14:00, il y a 4 heures 43 minutes Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Publié le 02/09/2026 à 14:00, il y a 4 heures 43 minutes Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Publié le 02/09/2026 à 13:00, il y a 5 heures 43 minutes Snipp-Powered Loyalty Programs Earn Two Gold Awards at Loyalty360 Awards
Publié le 02/09/2026 à 18:30, il y a 13 minutes RÉSULTAT DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ET EXTRAORDINAIRE DU 2 SEPTEMBRE 2026
Publié le 02/09/2026 à 18:15, il y a 28 minutes Haier Smart Home Co., Ltd. Launches Voluntary Public Share Buy-back Offer for up to 81,044,512 D-Shares at EUR 1.87
Publié le 02/09/2026 à 18:14, il y a 29 minutes Delivery Hero’s Management Board and Supervisory Board publish joint reasoned statement recommending shareholders to accept the takeover offer from Uber